{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:44:37Z","timestamp":1790711077500,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>COVID-19 causes acute respiratory distress syndrome (ARDS) and depletes the lungs of surfactant, leading to prolonged mechanical ventilation and death. The feasibility and safety of surfactant delivery in COVID-19 ARDS patients have not been established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed retrospective analyses of data from patients receiving off-label use of exogenous natural surfactant during the COVID-19 pandemic. Seven COVID-19 PCR positive ARDS patients received liquid Curosurf (720\u00a0mg) in 150\u00a0ml normal saline, divided into five 30\u00a0ml aliquots) and delivered via a bronchoscope into second-generation bronchi. Patients were matched with 14 comparable subjects receiving supportive care for ARDS during the same time period. Feasibility and safety were examined as well as the duration of mechanical ventilation and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients showed no evidence of acute decompensation following surfactant installation into minor bronchi. Cox regression showed a reduction of 28-days mortality within the surfactant group, though not significant. The surfactant did not increase the duration of ventilation, and health care providers did not convert to COVID-19 positive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Surfactant delivery through bronchoscopy at a dose of 720\u00a0mg in 150\u00a0ml normal saline is feasible and safe for COVID-19 ARDS patients and health care providers during the pandemic. Surfactant administration did not cause acute decompensation, may reduce mortality and mechanical ventilation duration in COVID-19 ARDS patients. This study supports the future performance of randomized clinical trials evaluating the efficacy of meticulous sub-bronchial lavage with surfactant as treatment for patients with COVID-19 ARDS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-020-01603-w","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T06:04:44Z","timestamp":1610949884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Surfactant therapy for COVID-19 related ARDS: a retrospective case\u2013control pilot study"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5483-8007","authenticated-orcid":false,"given":"Simone","family":"Piva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"DiBlasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April E.","family":"Slee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan H.","family":"Jobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo M.","family":"Roccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Filippini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Latronico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Portman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,18]]},"reference":[{"key":"1603_CR1","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708\u201320.","journal-title":"N Engl J Med"},{"key":"1603_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383:120\u20138.","journal-title":"N Engl J Med"},{"key":"1603_CR3","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00134-020-06033-2","volume":"46","author":"L Gattinoni","year":"2020","unstructured":"Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46:1099\u2013102.","journal-title":"Intensive Care Med"},{"key":"1603_CR4","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1164\/rccm.202003-0817LE","volume":"201","author":"L Gattinoni","year":"2020","unstructured":"Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 does not lead to a \u2018typical\u2019 acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;201:1299\u2013300.","journal-title":"Am J Respir Crit Care Med"},{"key":"1603_CR5","doi-asserted-by":"publisher","first-page":"2000607","DOI":"10.1183\/13993003.00607-2020","volume":"55","author":"RJ Mason","year":"2020","unstructured":"Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J. 2020;55:2000607.","journal-title":"Eur Respir J"},{"key":"1603_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420\u20132.","journal-title":"Lancet Respir Med"},{"key":"1603_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12931-014-0128-8","volume":"15","author":"A Dushianthan","year":"2014","unstructured":"Dushianthan A, Goss V, Cusack R, Grocott MPW, Postle AD. Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome. Respir Res. 2014;15:128.","journal-title":"Respir Res"},{"key":"1603_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet Lond Engl. 2020;395:497\u2013506.","journal-title":"China Lancet Lond Engl"},{"key":"1603_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12931-019-1220-x","volume":"20","author":"J Zebialowicz Ahlstr\u00f6m","year":"2019","unstructured":"Zebialowicz Ahlstr\u00f6m J, Massaro F, Mikolka P, et al. Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits. Respir Res. 2019;20:245.","journal-title":"Respir Res"},{"key":"1603_CR10","first-page":"CD001456","volume":"11","author":"FL Bahadue","year":"2012","unstructured":"Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;11:CD001456.","journal-title":"Cochrane Database Syst Rev"},{"key":"1603_CR11","doi-asserted-by":"publisher","first-page":"L32","DOI":"10.1152\/ajplung.00128.2017","volume":"314","author":"D Spengler","year":"2018","unstructured":"Spengler D, Winoto-Morbach S, Kupsch S, et al. Novel therapeutic roles for surfactant-inositols and -phosphatidylglycerols in a neonatal piglet ARDS model: a translational study. Am J Physiol Lung Cell Mol Physiol. 2018;314:L32\u201353.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1603_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ccc.2011.04.005","volume":"27","author":"K Raghavendran","year":"2011","unstructured":"Raghavendran K, Willson D, Notter RH. Surfactant therapy for acute lung injury and acute respiratory distress syndrome. Crit Care Clin. 2011;27:525\u201359.","journal-title":"Crit Care Clin"},{"key":"1603_CR13","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJM199605303342201","volume":"334","author":"A Anzueto","year":"1996","unstructured":"Anzueto A, Baughman RP, Guntupalli KK, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med. 1996;334:1417\u201321.","journal-title":"N Engl J Med"},{"key":"1603_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1378\/chest.09-0787","volume":"136","author":"RG Spragg","year":"2009","unstructured":"Spragg RG, Taut FJH, G\u00fcnther A, Rippin G. Surfactant replacement therapy in ARDS. Chest. 2009;136:321\u20132.","journal-title":"Chest"},{"key":"1603_CR15","first-page":"109s","volume":"3","author":"PS Richman","year":"1989","unstructured":"Richman PS, Spragg RG, Robertson B, Merritt TA, Curstedt T. The adult respiratory distress syndrome: first trials with surfactant replacement. Eur Respir J. 1989;3:109s\u2013111s.","journal-title":"Eur Respir J"},{"key":"1603_CR16","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1164\/rccm.201607-1401LE","volume":"195","author":"JB Grotberg","year":"2017","unstructured":"Grotberg JB, Filoche M, Willson DF, Raghavendran K, Notter RH. Did reduced alveolar delivery of surfactant contribute to negative results in adults with acute respiratory distress syndrome? Am J Respir Crit Care Med. 2017;195:538\u201340.","journal-title":"Am J Respir Crit Care Med"},{"issue":"76","key":"1603_CR17","first-page":"45","volume":"1994","author":"T Ueda","year":"1985","unstructured":"Ueda T, Ikegami M, Rider ED, Jobe AH. Distribution of surfactant and ventilation in surfactant-treated preterm lambs. J Appl Physiol Bethesda Md. 1985;1994(76):45\u201355.","journal-title":"J Appl Physiol Bethesda Md"},{"key":"1603_CR18","unstructured":"18ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307: 2526\u201333."},{"key":"1603_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1164\/rccm.201902-0334OC","volume":"201","author":"L Chen","year":"2020","unstructured":"Chen L, Sorbo LD, Grieco DL, et al. Potential for lung recruitment estimated by the recruitment-to-inflation ratio in acute respiratory distress syndrome. A clinical trial. Am J Respir Crit Care Med. 2020;201:178\u201387.","journal-title":"Am J Respir Crit Care Med"},{"key":"1603_CR20","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.4187\/respcare.04409","volume":"60","author":"DR Hess","year":"2015","unstructured":"Hess DR. Recruitment maneuvers and PEEP titration. Respir Care. 2015;60:1688\u2013704.","journal-title":"Respir Care"},{"key":"1603_CR21","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1001\/jama.292.19.2379","volume":"292","author":"C Guerin","year":"2004","unstructured":"Guerin C, Gaillard S, Lemasson S, et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA. 2004;292:2379\u201387.","journal-title":"JAMA"},{"key":"1603_CR22","unstructured":"Bergstralh EJ, Kosanke JL. Computerized matching of cases to controls. 1995.  https:\/\/www.mayo.edu\/research\/documents\/biostat-56pdf\/DOC-10026923."},{"key":"1603_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475\u201381.","journal-title":"Lancet Respir Med"},{"key":"1603_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12890-018-0761-y","volume":"19","author":"S-S Meng","year":"2019","unstructured":"Meng S-S, Chang W, Lu Z-H, et al. Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials. BMC Pulm Med. 2019;19:9.","journal-title":"BMC Pulm Med"},{"key":"1603_CR25","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1164\/rccm.200207-782OC","volume":"167","author":"RG Spragg","year":"2003","unstructured":"Spragg RG, Lewis JF, Wurst W, et al. Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant. Am J Respir Crit Care Med. 2003;167:1562\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"545\u201375","key":"1603_CR26","first-page":"ix","volume":"55","author":"DF Willson","year":"2008","unstructured":"Willson DF, Chess PR, Notter RH. Surfactant for pediatric acute lung injury. Pediatr Clin North Am. 2008;55(545\u201375):ix.","journal-title":"Pediatr Clin North Am"},{"key":"1603_CR27","doi-asserted-by":"crossref","unstructured":"The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301\u20138.","DOI":"10.1056\/NEJM200005043421801"},{"key":"1603_CR28","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1164\/ajrccm.159.3.9806069","volume":"159","author":"J Lewis","year":"1999","unstructured":"Lewis J, McCaig L, H\u00e4fner D, Spragg R, Veldhuizen R, Kerr C. Dosing and delivery of a recombinant surfactant in lung-injured adult sheep. Am J Respir Crit Care Med. 1999;159:741\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"1603_CR29","doi-asserted-by":"publisher","first-page":"9287","DOI":"10.1073\/pnas.1504025112","volume":"112","author":"M Filoche","year":"2015","unstructured":"Filoche M, Tai C-F, Grotberg JB. Three-dimensional model of surfactant replacement therapy. Proc Natl Acad Sci U S A. 2015;112:9287\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1603_CR30","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1183\/09031936.02.00243302","volume":"19","author":"A G\u00fcnther","year":"2002","unstructured":"G\u00fcnther A, Schmidt R, Harodt J, et al. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties. Eur Respir J. 2002;19:797\u2013804.","journal-title":"Eur Respir J"},{"issue":"5","key":"1603_CR31","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1183\/09031936.02.00243402","volume":"19","author":"D Walmrath","year":"2002","unstructured":"Walmrath D, Grimminger F, Pappert D, et al. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on gas exchange and haemodynamics. Eur Respir J. 2002;19(5):805\u201310.","journal-title":"Eur Respir J."}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01603-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-020-01603-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01603-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T06:08:27Z","timestamp":1610950107000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-020-01603-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,18]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1603"],"URL":"https:\/\/doi.org\/10.1186\/s12931-020-01603-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-78815\/v1","asserted-by":"object"}]},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,18]]},"assertion":[{"value":"15 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was submitted to our local ethics committee as a retrospective analysis. Given the retrospective nature of this study and in accordance with current legislation, the need for informed consent was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}